134 related articles for article (PubMed ID: 2433217)
21. Could HLA-DRB1 be the protective locus in rheumatoid arthritis?
Zanelli E; Gonzalez-Gay MA; David CS
Immunol Today; 1995 Jun; 16(6):274-8. PubMed ID: 7544977
[TBL] [Abstract][Full Text] [Related]
22. Expression of HLA-DR, DQ and DP antigens and interleukin-2 receptor on synovial fluid T lymphocyte subsets in rheumatoid arthritis: evidence for "frustrated" activation.
Pitzalis C; Kingsley G; Lanchbury JS; Murphy J; Panayi GS
J Rheumatol; 1987 Aug; 14(4):662-6. PubMed ID: 3118018
[TBL] [Abstract][Full Text] [Related]
23. Examination of two anti-HLA-DR-like monoclonal antibodies.
Nikolova EB
Haematologia (Budap); 1986; 19(2):133-40. PubMed ID: 2428703
[TBL] [Abstract][Full Text] [Related]
24. Cytotoxic human HLA class II restricted purified protein derivative-reactive T-lymphocyte clones. IV. Analysis of HLA restriction pattern and mycobacterial antigen specificity.
Hansen PW; Petersen CM; Povlsen JV; Kristensen T
Scand J Immunol; 1987 Mar; 25(3):295-303. PubMed ID: 3494302
[TBL] [Abstract][Full Text] [Related]
25. Structure of antigen-specific suppressor factors: current views.
Kontiainen SK; James RF; Culbert EJ; Feldmann M
Surv Immunol Res; 1982; 1(1):17-23. PubMed ID: 6195709
[No Abstract] [Full Text] [Related]
26. The human Ia system.
Winchester RJ; Kunkel HG
Adv Immunol; 1979; 28():221-92. PubMed ID: 94505
[No Abstract] [Full Text] [Related]
27. Lymphocytes. 1. Function. Genetic restrictions in the immune response.
McMichael AJ
J Clin Pathol Suppl (R Coll Pathol); 1979; 13():30-8. PubMed ID: 93114
[No Abstract] [Full Text] [Related]
28. The Epstein-Barr virus glycoprotein gp110, a molecular link between HLA DR4, HLA DR1, and rheumatoid arthritis.
Roudier J; Rhodes G; Petersen J; Vaughan JH; Carson DA
Scand J Immunol; 1988 Apr; 27(4):367-71. PubMed ID: 2452474
[No Abstract] [Full Text] [Related]
29. Class II molecules of the major histocompatibility complex considered as differentiation markers.
Radka SF; Charron DJ; Brodsky FM
Hum Immunol; 1986 Aug; 16(4):390-400. PubMed ID: 2428784
[No Abstract] [Full Text] [Related]
30. Dw subtypes of serologically defined DR-DQ specificities restrict recognition of cytomegalovirus.
Linner KM; Monroy C; Bach FH; Gehrz RC
Hum Immunol; 1986 Oct; 17(2):79-86. PubMed ID: 2428785
[TBL] [Abstract][Full Text] [Related]
31. Essential requirement for major histocompatibility complex recognition in T-cell tolerance induction.
Lamb JR; Feldmann M
Nature; 1984 Mar 1-7; 308(5954):72-4. PubMed ID: 6199675
[TBL] [Abstract][Full Text] [Related]
32. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen.
Gay D; Maddon P; Sekaly R; Talle MA; Godfrey M; Long E; Goldstein G; Chess L; Axel R; Kappler J
Nature; 1987 Aug 13-19; 328(6131):626-9. PubMed ID: 3112582
[TBL] [Abstract][Full Text] [Related]
33. Impaired lymphocyte responsiveness to phytohaemagglutinin associated with the possession of HLA-B8/DR3.
Amer A; Singh G; Darke C; Dolby AE
Tissue Antigens; 1986 Oct; 28(4):193-8. PubMed ID: 3492778
[TBL] [Abstract][Full Text] [Related]
34. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
35. Identification of two promiscuous T cell epitopes from tetanus toxin.
Ho PC; Mutch DA; Winkel KD; Saul AJ; Jones GL; Doran TJ; Rzepczyk CM
Eur J Immunol; 1990 Mar; 20(3):477-83. PubMed ID: 1690656
[TBL] [Abstract][Full Text] [Related]
36. Circulating HLA-DR bearing T cells: correlation with genetic rather than clinical variables.
Clegg DO; Pincus SH; Zone JJ; Ward JR
J Rheumatol; 1986 Oct; 13(5):870-4. PubMed ID: 3493345
[TBL] [Abstract][Full Text] [Related]
37. Allele-specific variation in the degeneracy of major histocompatibility complex (MHC) restriction.
Carmichael P; Copier J; So A; Lechler R
Hum Immunol; 1997 Apr; 54(1):21-9. PubMed ID: 9154454
[TBL] [Abstract][Full Text] [Related]
38. Structural requirements for recognition of the HLA-Dw14 class II epitope: a key HLA determinant associated with rheumatoid arthritis.
Hiraiwa A; Yamanaka K; Kwok WW; Mickelson EM; Masewicz S; Hansen JA; Radka SF; Nepom GT
Proc Natl Acad Sci U S A; 1990 Oct; 87(20):8051-5. PubMed ID: 1700425
[TBL] [Abstract][Full Text] [Related]
39. HLA-Dw14 and HLA-DR3 haplotypes share a functional determinant recognized by a human alloreactive T-cell clone.
Lang B; LoGalbo PR; Sanchez B; Winchester R
Hum Immunol; 1988 Sep; 23(1):59-70. PubMed ID: 2461353
[TBL] [Abstract][Full Text] [Related]
40. Functional polymorphism of the HLA-DR beta III chain.
Sheehy MJ; Rowe JR; Koning F; Jorgensen L
Hum Immunol; 1988 Jan; 21(1):49-61. PubMed ID: 2452815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
